GNAS mutation helps distinguish between IPMN and MCN.

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the CMID Test. Study with flashcards and multiple choice questions, each question contains hints and explanations. Get ready for your exam with confidence!

Multiple Choice

GNAS mutation helps distinguish between IPMN and MCN.

Explanation:
GNAS mutation testing targets the molecular signature of intraductal papillary mucinous neoplasms. This mutation is commonly found in IPMNs and reflects their origin from the pancreatic ducts with mucin-producing papillary growth. Because GNAS mutations are characteristic of IPMN and are not typical of mucinous cystic neoplasms, serous cystadenomas, or pseudocysts, detecting GNAS supports an IPMN diagnosis. The other cystic lesions generally lack GNAS mutations, so their presence would not point toward MCN or other entities. This is why identifying a GNAS mutation makes IPMN the best answer.

GNAS mutation testing targets the molecular signature of intraductal papillary mucinous neoplasms. This mutation is commonly found in IPMNs and reflects their origin from the pancreatic ducts with mucin-producing papillary growth. Because GNAS mutations are characteristic of IPMN and are not typical of mucinous cystic neoplasms, serous cystadenomas, or pseudocysts, detecting GNAS supports an IPMN diagnosis. The other cystic lesions generally lack GNAS mutations, so their presence would not point toward MCN or other entities. This is why identifying a GNAS mutation makes IPMN the best answer.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy